课题基金 / 基金详情

Species difference in hydroxylation of polychlorinated biphenyls and exposure of metabolites in human blood.

Species difference in hydroxylation of polychlorinated biphenyls and exposure of metabolites in human blood.
多氯联苯羟基化和人体血液中代谢物暴露的物种差异。
批准号:
16590101
负责人:
HARAGUCHI Koichi
金额:
$2.3万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

HARAGUCHI Koichi的其他基金

相似基金

相关文献

中文摘要
翻译
1.在多氯联苯的羟化代谢方面,研究了大鼠、小鼠、仓鼠和豚鼠在多氯联苯混合物(Kanechlor500)作用下的物种差异。在仓鼠体内大量产生邻苯二酚多氯联苯(主要是di0H-CBH0),而在大鼠和小鼠体内优先产生羟基化多氯联苯(主要是4-羟基-CB 107)和甲磺酰多氯联苯。豚鼠产生甲磺酰羟化的多氯联苯。所有二羟基多氯联苯都被发现来自2,5-或2,3,6-氯化多氯联苯。用大鼠、仓鼠和豚鼠的肝微粒体研究了PCB101的体外代谢。3-0H-,3‘-OH-,4’-OH-和3‘,4’-di0H-CB101分别由大鼠和豚鼠的肝微体形成。3‘-OH-CB101和4’-0H-CB101生成di0H-CB101的速率远高于CB101,苯巴比妥处理可加速生成di0H-CB101。结果表明,CB101向di0H-CB101的代谢主要是由CYP2B酶催化的,相对于CB101.3,该酶更倾向于4‘-0H-和3’-OH。人血中残留的羟基多氯联苯为4-0H-CB107、4-0H-CB146和4-0H-CB187。为了进一步研究二氢多氯联苯在人体内的负荷,采用电子捕获负电离-气相色谱-质谱仪(ECNI-GC)对福冈居民的血液样品进行了分析。结果在人体血液中检测到1种二氢二氯联苯,鉴定为4,5-(OH)_2-2,3,6,2‘,4’,5‘-六氯联苯(di0H-CB149)。羟基多氯联苯,包括儿茶酚多氯联苯,可能会降低人体内的甲状腺激素水平,因此需要进行进一步的监测和毒理学意义的研究。
英文摘要
1. In the hydroxylation metabolism of polychlorinated biphenyls (PCBs), species differences were studied in rats, mice, hamsters and guinea pigs dosed with PCB mixture (Kanechlor 500). Catechol PCBs (mainly di0H-CBH0) were highly produced in hamsters, while hydroxylated PCBs (mainly 4-OH-CB 107) and methylsulfonyl PCBs were preferably produced in rats and mice. Guinea pigs produced methylsulfonyl-hydroxylated PCBs. All diOH-PCBs were found to be derived from 2,5-or 2,3,6-chlorinated PCBs.2. The in vitro metabolism of PCB 101 was studied using liver microsomes of rats, hamsters and guinea pigs.3-0H-, 3'-OH-, 4'-OH-and 3',4'-di0H-CB101 were formed by liver microsomes of rats and guinea pigs. The formation of di0H-CB101 from 3'-OH-and 4'-0H-CB101 proceeded at much higher rate than that from CB101 and was accelerated by phenobarbital-treatment. The result indicated that the metabolism of CB 101 to di0H-CB101 is principally catalyzed by CYP2B enzymes, which prefer 4'-0H-and 3'-OH to CB101.3. Hydroxyl Ted PCBs retained in human blood were found to be 4-0H-CB107, 4-0H-CB146 and 4-0H-CB187.In order to further investigate the body burden of di0H-PCBs in human, blood samples from Fukuoka residents were analyzed by electron capture negative ionization-gas chromatography-mass spectrometry (ECNI-GC), using 18 synthesized references (veratrolic PCBs) for catechol metabolites. As a result, one di0H-PCB was detected in human blood, and identified as 4,5-(OH)_2-2,3,6,2',4',5'-hexaCB (di0H-CB149).Further monitoring and toxicological significance of hydroxylated PCBs including catecholic PCBs should be performed, since these metabolites may decrease the thyroxine levels in human body.
期刊论文(66)
专著(0)
科研奖励(0)
会议论文
2,2',3,4',5,5',6-七塩素化ビフェニル(CB187)の主代謝物の合成
2,2,3,4,5,5,6-七氯联苯(CB187)主要代谢物的合成
DOI: --
发表时间: 2006
期刊: 中村学園大学 研究紀要 38
影响因子: --
作者: [Yamaguchi Y, Yamada K, Yoshikawa N, Nakamura K, Haginaka J, Kunitomo M., T.Funahashi et al., M.Yotoriyama et al., T.Funahashi et al., K.Watanabe et al., T.Matsunaga et al., T.Funahashi et al., Yasuo Seto, 太田千穂]
通讯作者: 太田千穂
Species differences in tissue distribution of catechol and methylsulphonyl metabolites of polychlorinated biphenyls in rats, mice, hamsters and guinea pigs.
大鼠、小鼠、仓鼠和豚鼠体内儿茶酚和多氯联苯甲磺酰代谢物的组织分布存在物种差异。
DOI: --
发表时间: 2005
期刊: Xenobiotica (in press)
影响因子: --
作者: [K.Haraguchi, Y.Kato, N.Koga, M.Degawa]
通讯作者: M.Degawa
DOI: 10.1021/tx0498096
发表时间: 2004-12-01
期刊: CHEMICAL RESEARCH IN TOXICOLOGY
影响因子: 4.1
作者: [Haraguchi, K, Kato, Y, Degawa, M]
通讯作者: Degawa, M
Metabolism of 2, 3', 4, 4', 5-penta-chlorobiphenyl in guinea pig microsomes.
2, 3, 4, 4, 5-五氯联苯在豚鼠微粒体中的代谢。
DOI: --
发表时间: 2005
期刊: Fukuoka Acta Medica 96
影响因子: --
作者: [Chizuko Miyake-Nakayama, Sachiyo Masujima, Hisayoshi ikatsu, Shin-ich Miyoshi, Sumio Shinoda, Choji Fukuhara, Chiho Ohta]
通讯作者: Chiho Ohta
共 22 条
    Formation and bioconcentration of natural organohalogen compounds in Asia-Pacific food web
    Research of antibacterial chemicals in marine sponge and development of lead compounds for therapy in infectious diseases
    Environmental Research of naturally produced lipophilic halogenated compounds in Oceania
    Metabolism of polychlorinated and polybrominated pollutants in mammals and human health
    • 批准号:
      12672180
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.05万
    • 财政年份:
      2000
    • 负责人:
      HARAGUCHI Koichi
    • 依托单位:
    海外基金